| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/IBD.3780040406 |
| P698 | PubMed publication ID | 9836081 |
| P2093 | author name string | P K Das | |
| A A Te Velde | |||
| S J Van Deventer | |||
| A J Tigges | |||
| L Camoglio | |||
| P433 | issue | 4 | |
| P921 | main subject | inflammatory bowel diseases | Q917447 |
| P304 | page(s) | 285-290 | |
| P577 | publication date | 1998-11-01 | |
| P1433 | published in | Inflammatory Bowel Diseases | Q15749161 |
| P1476 | title | Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease | |
| P478 | volume | 4 |
| Q26827500 | A review on chemical-induced inflammatory bowel disease models in rodents |
| Q44406128 | CCR4 is an up-regulated chemokine receptor of peripheral blood memory CD4+ T cells in Crohn's disease |
| Q33678275 | Chronic inflammation and cytokines in the tumor microenvironment |
| Q64049684 | Chronic recurrent multifocal osteomyelitis associated with chronic inflammatory bowel disease in children |
| Q33984746 | Colonic expression of gamma-interferon and interleukin-10 in Crohn's disease and ulcerative colitis |
| Q35919106 | Cytokine profiles in peripheral blood of children and adults with Crohn disease |
| Q34345020 | Cytokine regulation of OCTN2 expression and activity in small and large intestine |
| Q35737476 | Deficiency of Nuclear Receptor Nur77 Aggravates Mouse Experimental Colitis by Increased NFκB Activity in Macrophages |
| Q89861763 | Development of Physiologically Responsive Human iPSC-Derived Intestinal Epithelium to Study Barrier Dysfunction in IBD |
| Q90088493 | Diagnostic Challenges in the Early Onset of Inflammatory Bowel Disease: A Case Report |
| Q48102227 | EGCG Maintains Th1/Th2 Balance and Mitigates Ulcerative Colitis Induced by Dextran Sulfate Sodium through TLR4/MyD88/NF-κB Signaling Pathway in Rats. |
| Q82835935 | Emu oil increases colonic crypt depth in a rat model of ulcerative colitis |
| Q47230046 | Endolysosomal Cation Channels and Cancer-A Link with Great Potential. |
| Q55254664 | Enhanced Utilization of Induced Pluripotent Stem Cell-Derived Human Intestinal Organoids Using Microengineered Chips. |
| Q45733926 | Evidence of Epstein-Barr virus infection in ulcerative colitis |
| Q37374943 | From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited |
| Q42438490 | Histological and immunological features of appendix in patients with ulcerative colitis |
| Q35082666 | IFNG rs1861494 polymorphism is associated with IBD disease severity and functional changes in both IFNG methylation and protein secretion |
| Q73122554 | IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease |
| Q36769500 | Immune dysfunction in inflammatory bowel disease |
| Q36125752 | Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease |
| Q42003625 | Immunomodulation of human intestinal T cells by the synthetic CD80 antagonist RhuDex® |
| Q44322264 | Inflammation modulates fibronectin isoform expression in colonic lamina propria fibroblasts (CLPF). |
| Q24673592 | Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract |
| Q28571586 | Interleukin-11-induced heat shock protein 25 confers intestinal epithelial-specific cytoprotection from oxidant stress |
| Q52617363 | Mbd2 enables tumourigenesis within the intestine while preventing tumour-promoting inflammation. |
| Q50952715 | Microscopic Colitis Evolved Into Inflammatory Bowel Diseases Is Characterized by Increased Th1/Tc1 Cells in Colonic Mucosal Lamina Propria. |
| Q37762230 | Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors? |
| Q54200104 | No association between the SOCS-1 -1478CA/del polymorphism and ulcerative colitis in Turkish subjects. |
| Q48351328 | Old and New Lymphocyte Players in Inflammatory Bowel Disease |
| Q39753169 | Production of interferon-gamma by activated T-cell receptor-alphabeta CD8alphabeta intestinal intraepithelial lymphocytes is required and sufficient for disruption of the intestinal barrier integrity |
| Q35061825 | STAT6 activation in ulcerative colitis: a new target for prevention of IL-13-induced colon epithelial cell dysfunction |
| Q41638096 | The GPR55 antagonist CID16020046 protects against intestinal inflammation. |
| Q55222890 | The Role of T-Cell Subsets in Chronic Inflammation in Celiac Disease and Inflammatory Bowel Disease Patients: More Common Mechanisms or More Differences? |
| Q43965504 | The natural plant product tryptanthrin ameliorates dextran sodium sulfate-induced colitis in mice |
| Q33294346 | The proinflammatory CXC-chemokines GRO-alpha/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids |
Search more.